Top compounds associated with response to OR2V2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.06
mRNA GW 441756 GDSC1000 pan-cancer AAC -0.068 0.06
mRNA OSI-930 GDSC1000 pan-cancer AAC -0.065 0.06
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.065 0.06
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.06
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.056 0.07
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.061 0.07
mRNA tigecycline CTRPv2 pan-cancer AAC -0.086 0.07
mRNA cabozantinib CTRPv2 pan-cancer AAC -0.065 0.07
mRNA AT-7519 GDSC1000 pan-cancer AAC -0.055 0.07
Download CSV